These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 2864750)
41. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction. Kolind MP; Nørby PL; Berchtold MW; Johnsen LB J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947 [TBL] [Abstract][Full Text] [Related]
42. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue. Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118 [TBL] [Abstract][Full Text] [Related]
43. Structure and function of a recombinant von Willebrand factor drug candidate. Turecek PL; Schrenk G; Rottensteiner H; Varadi K; Bevers E; Lenting P; Ilk N; Sleytr UB; Ehrlich HJ; Schwarz HP Semin Thromb Hemost; 2010 Jul; 36(5):510-21. PubMed ID: 20635317 [TBL] [Abstract][Full Text] [Related]
44. von Willebrand factor. A protein which binds at the cell surface interface between platelets. Senogles SE; Nelsestuen GL J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342 [TBL] [Abstract][Full Text] [Related]
45. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium. Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553 [TBL] [Abstract][Full Text] [Related]
46. Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein. Gralnick HR; Williams SB; Rick ME Proc Natl Acad Sci U S A; 1983 May; 80(9):2771-4. PubMed ID: 6601805 [TBL] [Abstract][Full Text] [Related]
47. Proceedings: Interaction of ristocetin (R), von Willebrand factor (vWF), factor VIII clotting activity (VIIIc) and platelets. Zucker MB; McPherson J; Kim SJ; Macdonald VE; Taylor D; Johnson AJ; Barlow GH Thromb Diath Haemorrh; 1975 Nov; 34(2):582. PubMed ID: 1081748 [No Abstract] [Full Text] [Related]
48. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition. Sixma JJ; Sakariassen KS; Beeser-Visser NH; Ottenhof-Rovers M; Bolhuis PA Blood; 1984 Jan; 63(1):128-39. PubMed ID: 6418228 [TBL] [Abstract][Full Text] [Related]
49. Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size. Federici AB; Bader R; Pagani S; Colibretti ML; De Marco L; Mannucci PM Br J Haematol; 1989 Sep; 73(1):93-9. PubMed ID: 2803984 [TBL] [Abstract][Full Text] [Related]
50. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b. Carew JA; Quinn SM; Stoddart JH; Lynch DC J Clin Invest; 1992 Dec; 90(6):2258-67. PubMed ID: 1469086 [TBL] [Abstract][Full Text] [Related]
51. Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand's disease. Gralnick HR; Cregger MC; Williams SB Blood; 1982 Mar; 59(3):542-8. PubMed ID: 6800417 [TBL] [Abstract][Full Text] [Related]
52. Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets. Ruggeri ZM; Bader R; de Marco L Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6038-41. PubMed ID: 6310559 [TBL] [Abstract][Full Text] [Related]
53. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor. Foster PA; Fulcher CA; Houghten RA; Zimmerman TS Thromb Haemost; 1990 Jun; 63(3):403-6. PubMed ID: 2119526 [TBL] [Abstract][Full Text] [Related]
54. Platelet factor 4 does not promote von Willebrand factor binding to human platelets. Levine SP; Moake JL Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307 [TBL] [Abstract][Full Text] [Related]
55. Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain. Girma JP; Chopek MW; Titani K; Davie EW Biochemistry; 1986 Jun; 25(11):3156-63. PubMed ID: 3015200 [TBL] [Abstract][Full Text] [Related]
56. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. Phillips MD; Moake JL; Nolasco L; Turner N Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193 [TBL] [Abstract][Full Text] [Related]
57. Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cryoprecipitate and different factor VIII concentrates. López-Fernández MF; López-Berges C; Corral M; García-Talavera JR; López Borrasca A; Batlle J Vox Sang; 1987; 52(1-2):15-9. PubMed ID: 3111088 [TBL] [Abstract][Full Text] [Related]
58. Localization of surface vWF on resting and stimulated platelets. Rand JH; Gordon RE; Uson RR; Potter BJ Blood; 1987 Nov; 70(5):1297-302. PubMed ID: 2822169 [TBL] [Abstract][Full Text] [Related]
59. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo. Hamilton KK; Fretto LJ; Grierson DS; McKee PA J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727 [TBL] [Abstract][Full Text] [Related]
60. Plasma and platelet von Willebrand factor defects in uremia. Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]